Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery

NCT05702827 is registered in ClinicalTrials.gov with TriHealth Inc. as lead sponsor.

NCT NCT05702827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05702827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery
Lead sponsor
TriHealth Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 23, 2023
Completion date
April 18, 2024
Enrollment
148 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pain vulva, stress urinary incontinence, surgical incision